Skip to content
Screener

McKesson MCK Restructuring and Asset Impairment Charges

Restructuring and Asset Impairment Charges at other companies

Howmet Aerospace logo
Howmet AerospaceHWM
-$93M-2,225%
Ciena logo
CienaCIEN
$1.5M-3.0%
Xylem logo
XylemXYL
$31M+47.6%
Smurfit Kappa Group logo
Smurfit Kappa GroupSW
$54M+260%
Staar Surgical logo
Staar SurgicalSTAA
$2.68M-88.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$101.59B+15.6%
Enterprise value$109.31B+13.4%
P/E22.1×-5.7×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%—
Debt / equity2×—
Current ratio0.9×0.0×